<DOC>
	<DOC>NCT02553421</DOC>
	<brief_summary>This study will examine the use of the ivWatch Model 400 to monitor PIV sites in pediatric patients. Half the participants will be monitored by the device without infiltration notifications and the other half will be monitored by the device with infiltration notifications enabled.</brief_summary>
	<brief_title>Optical Detection of Intravenous Infiltration:A Pilot Study</brief_title>
	<detailed_description />
	<criteria>Signed consent and/or assent Newborn to 17 years of age Weight &gt; 2.5 kg Severe skin integrity issues such as severe eczema, burns, epidermolysis bullosa, rash, hives Severe scarring of tissue (excessive IV use) Tattoo in area of PIV site IV site located in antecubital fossa</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>infiltration</keyword>
	<keyword>extravasation</keyword>
	<keyword>peripheral intravenous therapy</keyword>
</DOC>